Download PDF
J Pediatr Genet 2016; 05(02): 116-123
DOI: 10.1055/s-0036-1579757
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Von Hippel–Lindau Disease

Jennifer J. Findeis-Hosey
1   Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
,
Kelly Q. McMahon
2   Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
3   Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
,
Sarah K. Findeis
4   The Pennsylvania State University School of Medicine and Dentistry, Hershey, Pennsylvania, United States
› Author Affiliations
Further Information

Publication History

15 July 2015

10 August 2015

Publication Date:
04 April 2016 (online)

Also available at
    Permissions and Reprints

Abstract

Von Hippel–Lindau disease is an autosomal dominant syndrome which occurs secondary to germline mutations in the VHL tumor suppressor gene, located on chromosome 3. Clinically von Hippel–Lindau disease is characterized by an increased risk of developing simple visceral cysts, most commonly in the pancreas and kidneys, in addition to an increased risk of developing neoplasms, often with clear cell features, in a multitude of organ systems. The most common neoplasms are cerebellar and retinal hemangioblastomas, adrenal pheochromocytomas, clear cell renal cell carcinomas, pancreatic neuroendocrine tumors, pancreatic serous cystadenomas, and endolymphatic sac tumors. These lesions most commonly present during adulthood; however, screening and surveillance for the development of these lesions should begin in the pediatric years for patients with von Hippel–Lindau disease. In this review article, the genetics and most common neoplasms of von Hippel–Lindau disease are reviewed, with an eye towards implications for the pediatric patient.

Keywords

von Hippel–Lindau - pathology - pediatric
 

  • References

  • 1 Neumann HPH, Zbar B. Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int 1997; 51 (1) 16-26
    CrossrefPubMedGoogle Scholar
  • 2 von Hippel E. Über eine sehr seltene Erkrankung der Netzhaut. Graefe Arch Ophthalmol 1904; 59: 83-106
    PubMedGoogle Scholar
  • 3 Lindau A. Zur Frage der Angiomatosis Retinae und Ihrer Hirncomplikation. Acta Ophthalmol 1927; 4: 193-226
    PubMedGoogle Scholar
  • 4 Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 2011; 19 (6) 617-623
    CrossrefPubMedGoogle Scholar
  • 5 Friedrich CA. Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 2001; 10 (7) 763-767
    CrossrefPubMedGoogle Scholar
  • 6 Knudson AG. Cancer genetics. Am J Med Genet 2002; 111 (1) 96-102
    CrossrefPubMedGoogle Scholar
  • 7 Seizinger BR, Rouleau GA, Ozelius LJ , et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988; 332 (6161) 268-269
    CrossrefPubMedGoogle Scholar
  • 8 Latif F, Tory K, Gnarra J , et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993; 260 (5112) 1317-1320
    CrossrefPubMedGoogle Scholar
  • 9 Linehan WM, Lerman MI, Zbar B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 1995; 273 (7) 564-570
    CrossrefPubMedGoogle Scholar
  • 10 Kaelin Jr WG. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2002; 2 (9) 673-682
    CrossrefPubMedGoogle Scholar
  • 11 Shuin T, Yamasaki I, Tamura K, Okuda H, Furihata M, Ashida S. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol 2006; 36 (6) 337-343
    CrossrefPubMedGoogle Scholar
  • 12 Gnarra JR, Tory K, Weng Y , et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994; 7 (1) 85-90
    CrossrefPubMedGoogle Scholar
  • 13 Kanno H, Kuratsu J, Nishikawa R , et al. Clinical features of patients bearing central nervous system hemangioblastoma in von Hippel-Lindau disease. Acta Neurochir (Wien) 2013; 155 (1) 1-7
    CrossrefPubMedGoogle Scholar
  • 14 Melmon KL, Rosen SW. Lindau's disease. Review of the literature and study of a large kindred. Am J Med 1964; 36: 595-617
    CrossrefPubMedGoogle Scholar
  • 15 Stolle C, Glenn G, Zbar B , et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998; 12 (6) 417-423
    CrossrefPubMedGoogle Scholar
  • 16 Glenn GM, Linehan WM, Hosoe S , et al. Screening for von Hippel-Lindau disease by DNA-polymorphism analysis. J Am Med Assoc 1992; 267: 1226-1231
    CrossrefPubMedGoogle Scholar
  • 17 Nordstrom-O'Brien M, van der Luijt RB, van Rooijen E , et al. Genetic analysis of von Hippel-Lindau disease. Hum Mutat 2010; 31: 521-537
    PubMedGoogle Scholar
  • 18 Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer 2015; 15 (1) 55-64
    PubMedGoogle Scholar
  • 19 Chen F, Kishida T, Yao M , et al. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 1995; 5 (1) 66-75
    CrossrefPubMedGoogle Scholar
  • 20 Maher ER, Webster AR, Richards FM , et al. Phenotypic expression in von Hippel- Lindau disease: Correlations with germline VHL gene mutations. J Med Genet 1996; 33: 328-332
    CrossrefPubMedGoogle Scholar
  • 21 Crossey PA, Richards FM, Foster K , et al. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 1994; b: 3: 1303-1308
    CrossrefPubMedGoogle Scholar
  • 22 Stebbins CE, Kaelin Jr WG, Pavletich NP. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 1999; 284: 455-461
    CrossrefPubMedGoogle Scholar
  • 23 Brauch H, Kishida T, Glavac D , et al. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of GermanyL Evidence for a founder effect. Hum Genet 1996; 95: 551-556
    PubMedGoogle Scholar
  • 24 Ritter MM, Frilling A, Crossey PA , et al. Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. J Clin Endocrinol Metab 1996; 81: 1035-1037
    CrossrefPubMedGoogle Scholar
  • 25 McNeill A, Rattenberry E, Barber R, Killick P, MacDonald F, Maher ER. Genotype-phenotype correlations in VHL exon deletions. Am J Med Genet A 2009; 149A: 2147-2151
    CrossrefPubMedGoogle Scholar
  • 26 Maranchie JK, Afonso A, Albert PS , et al. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Hum Mutat 2004; 23: 40-46
    CrossrefPubMedGoogle Scholar
  • 27 Woodward ER, Eng C, McMahon R , et al. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL. Hum Mol Genet 1997; 6 (7) 1051-1056
    CrossrefPubMedGoogle Scholar
  • 28 Neumann HP, Bausch B, McWhinney SR , et al; Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002; 346 (19) 1459-1466
    CrossrefPubMedGoogle Scholar
  • 29 Hes FJ, McKee S, Taphoorn MJ , et al. Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only. J Med Genet 2000; b: 37: 939-943
    CrossrefPubMedGoogle Scholar
  • 30 Maher ER, Iselius L, Yates JR , et al. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991; 28 (7) 443-447
    CrossrefPubMedGoogle Scholar
  • 31 Sgambati MT, Stolle C, Choyke PL , et al. Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am J Hum Genet 2000; 66 (1) 84-91
    CrossrefPubMedGoogle Scholar
  • 32 Richards FM, Payne SJ, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet 1995; 4 (11) 2139-2143
    CrossrefPubMedGoogle Scholar
  • 33 Youssoufian H, Pyeritz RE. Mechanisms and consequences of somatic mosaicism in humans. Nat Rev Genet 2002; 3 (10) 748-758
    CrossrefPubMedGoogle Scholar
  • 34 van der Meulen MA, van der Meulen MJ, te Meerman GJ. Recurrence risk for germinal mosaics revisited. J Med Genet 1995; 32 (2) 102-104
    CrossrefPubMedGoogle Scholar
  • 35 Hall JG. Review and hypotheses: somatic mosaicism: observations related to clinical genetics. Am J Hum Genet 1988; 43 (4) 355-363
    PubMedGoogle Scholar
  • 36 Lamiell JM, Salazar FG, Hsia YE. von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 1989; 68 (1) 1-29
    CrossrefPubMedGoogle Scholar
  • 37 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK , eds. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press; 2007
    Google Scholar
  • 38 Niemelä M, Lemeta S, Sainio M , et al. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease. Invest Ophthalmol Vis Sci 2000; 41 (7) 1909-1915
    PubMedGoogle Scholar
  • 39 Neumann HPH, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P. Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 1989; 70 (1) 24-30
    CrossrefPubMedGoogle Scholar
  • 40 Vougioukas VI, Gläsker S, Hubbe U , et al. Surgical treatment of hemangioblastomas of the central nervous system in pediatric patients. Childs Nerv Syst 2006; 22 (9) 1149-1153
    CrossrefPubMedGoogle Scholar
  • 41 Jung SM, Kuo TT. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol 2005; 18 (6) 788-794
    CrossrefPubMedGoogle Scholar
  • 42 Slater A, Moore NR, Huson SM. The natural history of cerebellar hemangioblastomas in von Hippel-Lindau disease. AJNR Am J Neuroradiol 2003; 24 (8) 1570-1574
    PubMedGoogle Scholar
  • 43 Ammerman JM, Lonser RR, Dambrosia J, Butman JA, Oldfield EH. Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment. J Neurosurg 2006; 105 (2) 248-255
    CrossrefPubMedGoogle Scholar
  • 44 Maher ER, Yates JRW, Harries R , et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990; 77 (283) 1151-1163
    CrossrefPubMedGoogle Scholar
  • 45 Jagannathan J, Lonser RR, Smith R, DeVroom HL, Oldfield EH. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2008; 108 (2) 210-222
    CrossrefPubMedGoogle Scholar
  • 46 Singh AD, Shields CL, Shields JA. von Hippel-Lindau disease. Surv Ophthalmol 2001; 46 (2) 117-142
    CrossrefPubMedGoogle Scholar
  • 47 Kuo M-T, Kou H-K, Kao M-L, Tsai M-H, Chen Y-J, Lin S-A. Retinal capillary hemangiomas: clinical manifestations and visual prognosis. Chang Gung Med J 2002; 25 (10) 672-682
    PubMedGoogle Scholar
  • 48 Wong WT, Agrón E, Coleman HR , et al. Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease. Ophthalmology 2008; 115 (1) 181-188
    CrossrefPubMedGoogle Scholar
  • 49 Gaudric A, Krivosic V, Duguid G, Massin P, Giraud S, Richard S. Vitreoretinal surgery for severe retinal capillary hemangiomas in von hippel-lindau disease. Ophthalmology 2011; 118 (1) 142-149
    CrossrefPubMedGoogle Scholar
  • 50 Browne TR, Adams RD, Roberson GH. Hemangioblastoma of the spinal cord. Review and report of five cases. Arch Neurol 1976; 33 (6) 435-441
    CrossrefPubMedGoogle Scholar
  • 51 Na JH, Kim HS, Eoh W, Kim JH, Kim JS, Kim E-S. Spinal cord hemangioblastoma : diagnosis and clinical outcome after surgical treatment. J Korean Neurosurg Soc 2007; 42 (6) 436-440
    CrossrefPubMedGoogle Scholar
  • 52 Weil RJ, Lonser RR, DeVroom HL, Wanebo JE, Oldfield EH. Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2003; 98 (1) 95-105
    CrossrefPubMedGoogle Scholar
  • 53 Lonser RR, Weil RJ, Wanebo JE, DeVroom HL, Oldfield EH. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2003; 98 (1) 106-116
    CrossrefPubMedGoogle Scholar
  • 54 Barrisford GW, Singer EA, Rosner IL, Linehan WM, Bratslavsky G. Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol 2011; ;2011, Article ID 658767
    PubMedGoogle Scholar
  • 55 Keeler III LL, Klauber GT. Von Hippel-Lindau disease and renal cell carcinoma in a 16-year-old boy. J Urol 1992; 147 (6) 1588-1591
    PubMedGoogle Scholar
  • 56 Paraf F, Chauveau D, Chrétien Y, Richard S, Grünfeld JP, Droz D. Renal lesions in von Hippel-Lindau disease: immunohistochemical expression of nephron differentiation molecules, adhesion molecules and apoptosis proteins. Histopathology 2000; 36 (5) 457-465
    CrossrefPubMedGoogle Scholar
  • 57 Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6 (7) 655-663
    CrossrefPubMedGoogle Scholar
  • 58 Yang B, Autorino R, Remer EM , et al. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: The Cleveland Clinic experience with 3 years follow-up. Urol Oncol 2013; 31: 686-692
    CrossrefPubMedGoogle Scholar
  • 59 Baghai M, Thompson GB, Young Jr WF, Grant CS, Michels VV, van Heerden JA. Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg 2002; 137 (6) 682-688 , discussion 688–689
    PubMedGoogle Scholar
  • 60 Fishbein L, Merrill S, Fraker DL, Cohen DL, Nathanson KL. Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing. Ann Surg Oncol 2013; 20 (5) 1444-1450
    CrossrefPubMedGoogle Scholar
  • 61 McNicol AM. Update on tumours of the adrenal cortex, phaeochromocytoma and extra-adrenal paraganglioma. Histopathology 2011; 58 (2) 155-168
    CrossrefPubMedGoogle Scholar
  • 62 Opocher G, Conton P, Schiavi F, Macino B, Mantero F. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1. Fam Cancer 2005; 4 (1) 13-16
    CrossrefPubMedGoogle Scholar
  • 63 Havekes B, Romijn JA, Eisenhofer G, Adams K, Pacak K. Update on pediatric pheochromocytoma. Pediatr Nephrol 2009; 24 (5) 943-950
    CrossrefPubMedGoogle Scholar
  • 64 Neumann HP, Dinkel E, Brambs H , et al. Pancreatic lesions in the von Hippel-Lindau syndrome. Gastroenterology 1991; 101 (2) 465-471
    CrossrefPubMedGoogle Scholar
  • 65 van Asselt SJ, de Vries EGE, van Dullemen HM , et al. Pancreatic cyst development: insights from von Hippel-Lindau disease. Cilia 2013; 2 (1) 3
    CrossrefPubMedGoogle Scholar
  • 66 Volkan Adsay N. Cystic lesions of the pancreas. Mod Pathol 2007; 20 (Suppl. 01) S71-S93
    CrossrefPubMedGoogle Scholar
  • 67 Blansfield JA, Choyke L, Morita SY , et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery 2007; 142 (6) 814-818 , discussion 818.e1–818.e2
    CrossrefPubMedGoogle Scholar
  • 68 Marcos HB, Libutti SK, Alexander HR , et al. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison. Radiology 2002; 225 (3) 751-758
    CrossrefPubMedGoogle Scholar
  • 69 Chen M, Van Ness M, Guo Y, Gregg J. Molecular pathology of pancreatic neuroendocrine tumors. J Gastrointest Oncol 2012; 3 (3) 182-188
    PubMedGoogle Scholar
  • 70 Lubensky IA, Pack S, Ault D , et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol 1998; 153 (1) 223-231
    CrossrefPubMedGoogle Scholar
  • 71 Frankel WL. Update on pancreatic endocrine tumors. Arch Pathol Lab Med 2006; 130 (7) 963-966
    PubMedGoogle Scholar
  • 72 Asa SL. Pancreatic endocrine tumors. Mod Pathol 2011; 24 (Suppl. 02) S66-S77
    CrossrefPubMedGoogle Scholar
  • 73 Bosman FT, Carneiro F, Hruban RH, Theise ND , eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010
    Google Scholar
  • 74 Tamura K, Nishimori I, Ito T, Yamasaki I, Igarashi H, Shuin T. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease. World J Gastroenterol 2010; 16 (36) 4515-4518
    CrossrefPubMedGoogle Scholar
  • 75 Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-del Castillo C. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg 2005; 242 (3) 413-419 , discussion 419–421
    PubMedGoogle Scholar
  • 76 Wind JJ, Lonser RR. Management of von Hippel-Lindau disease-associated CNS lesions. Expert Rev Neurother 2011; 11 (10) 1433-1441
    CrossrefPubMedGoogle Scholar
  • 77 Brandt R. Aur erage der angiomatosis retinae. Von Graefes Arch Ophthalmol 1921; 106: 127-136
    PubMedGoogle Scholar
  • 78 Lindau A. Studies on cerebellar cysts: development, pathogenesis, and relationship with retinal angiomatosis. Acta Pathol Microbiol Scand Suppl 1926; 1: 1-128
    PubMedGoogle Scholar
  • 79 Hassard AD, Boudreau SF, Cron CC. Adenoma of the endolymphatic sac. J Otolaryngol 1984; 13 (4) 213-216
    PubMedGoogle Scholar
  • 80 Heffner DK. Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer 1989; 64 (11) 2292-2302
    CrossrefPubMedGoogle Scholar
  • 81 Gläsker S, Lonser RR, Tran MG , et al. Effects of VHL deficiency on endolymphatic duct and sac. Cancer Res 2005; 65 (23) 10847-10853
    CrossrefPubMedGoogle Scholar
  • 82 Choo D, Shotland L, Mastroianni M , et al. Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg 2004; 100 (3) 480-487
    CrossrefPubMedGoogle Scholar
  • 83 Kim HJ, Hagan M, Butman JA , et al. Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications. Laryngoscope 2013; 123 (2) 477-483
    CrossrefPubMedGoogle Scholar
  • 84 Family Alliance VHL. The VHL Handbook: What You Need to Know about VHL. 4th ed. 2012. Available at: http://vhl.org/wordpress/library/Handbook/handbook40.pdf . Accessed July 11, 2015
    PubMedGoogle Scholar